A prospective, randomised, controlled clinical study on the assessment of tolerability and of clinical efficacy of Merional (hMG-IBSA) administered subcutaneously versus Merional administered intramuscularly in women undergoing multifollicular ovarian stimulation in an ART programme (IVF)

• Hoofdauteurs: Massobrio Marco (Auteur), Strina Ida (Auteur), Fedele Luigi (Auteur), Ranieri Antonio (Auteur), Anserini Paola (Auteur), Revelli Alberto (Auteur), Alviggi Carlo (Auteur), Ragni Nicola (Auteur), De Placido Giuseppe (Auteur)
• Formaat: Boek
• Gepubliceerd in: BMC, 2007-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Multifollicular ovarian stimulation (MOS) is widely used in IVF and the compliance to treatment is deeply influenced by the tolerability of the medication(s) used and by the ease of self-administration. This prospective, controlled,...